Fisioterapia, Medicina y Ciencias Biomédicas
Departamento
Universidad de La Laguna
San Cristobal de La Laguna, EspañaPublicaciones en colaboración con investigadores/as de Universidad de La Laguna (11)
2023
-
Maximal Respiratory Pressure Reference Equations in Healthy Adults and Cut-off Points for Defining Respiratory Muscle Weakness
Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 813-820
2022
-
Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables
Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096
2021
-
Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Reply
Rheumatology (Oxford, England), Vol. 60, Núm. 3, pp. e120-e121
-
Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study
Reumatologia Clinica, Vol. 17, Núm. 8, pp. 461-470
-
Transcranial magnetic stimulation for the treatment of cocaine addiction: A systematic review
Journal of Clinical Medicine, Vol. 10, Núm. 23
2020
-
Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study
Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170
-
Prevalence of systemic lupus erythematosus in Spain: Higher than previously reported in other countries?
Rheumatology (United Kingdom), Vol. 59, Núm. 9, pp. 2556-2562
2019
-
Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96
2017
-
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3